Compounds > erlotinib hydrochloride
Page last updated: 2024-09-05

erlotinib hydrochloride and Cytomegalic Inclusion Disease

erlotinib hydrochloride has been researched along with Cytomegalic Inclusion Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hsu, CK; Lee, CN; Po-Chao Chiu, F1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Cytomegalic Inclusion Disease

ArticleYear
Cutaneous cytomegalovirus (CMV) infection in a patient with metastasized lung cancer.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021, Volume: 27, Issue:4

    Topics: Adenocarcinoma of Lung; Aged; Antineoplastic Agents; Cytomegalovirus Infections; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male

2021